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B I O C H E M I S T R Y
UFMylation of MRE11 is essential for telomere length 
maintenance and hematopoietic stem cell survival
Lara Lee1†, Ana Belen Perez Oliva2,3†, Elena Martinez-Balsalobre2, Dmitri Churikov1‡, Joshua Peter4, 
Dalicya Rahmouni1, Gilles Audoly1, Violette Azzoni1, Stephane Audebert1, Luc Camoin1, 
Victoriano Mulero2,3, Maria L. Cayuela2, Yogesh Kulathu4, Vincent Geli1‡, Christophe Lachaud1*
Ubiquitin-fold modifier 1 (UFM1) is involved in neural and erythroid development, yet its biological roles in these 
processes are unknown. Here, we generated zebrafish models deficient in Ufm1 and Ufl1 that exhibited telomere 
shortening associated with developmental delay, impaired hematopoiesis and premature aging. We further re-
port that HeLa cells lacking UFL1 have instability of telomeres replicated by leading-strand synthesis. We uncover 
that MRE11 UFMylation is necessary for the recruitment of the phosphatase PP1- leading to dephosphorylation 
of NBS1. In the absence of UFMylation, NBS1 remains phosphorylated, thereby reducing MRN recruitment to telo-
meres. The absence of MRN at telomeres favors the formation of the TRF2-Apollo/SNM1 complex consistent with the 
loss of leading telomeres. These results suggest that MRE11-UFMylation may serve as module to recruit PP1-. 
Last, zebrafish expressing Mre11 that cannot be UFMylated phenocopy Ufm1-deficient zebrafish, demon-
strating that UFMylation of MRE11 is a previously undescribed evolutionarily conserved mechanisms regulating 
telomere length.
INTRODUCTION
The ubiquitin family of proteins consists of Ubiquitin (Ub), and the 
other ubiquitin-like (Ubl) proteins, all of which share the same 
-grasp fold, are posttranslational modifiers that play a central role 
in a variety of cellular processes, including cell cycle progression, 
DNA damage response, protein translation and stability, signal 
transduction, intracellular trafficking, and antiviral response (1). 
Ubiquitin-fold modifier 1 (UFM1) is one of the most recently iden-
tified Ubls. It is evolutionarily conserved, and its orthologs are 
found in Metazoa and plants but not in yeast (2). The process of 
protein modification by UFM1 involves an enzymatic cascade sim-
ilar to that described for the other ubiquitin family members. Briefly, 
after cleavage of the last two amino acids of pro-UFM1 by the pep-
tidase UFSP2, UFM1 is activated by the UFM1-specific E1 enzyme 
UBA5, transferred to the E2-conjugating enzyme UFC1 before be-
ing ligated onto substrates by the E3 ligase UFL1. UFMylation is 
reversible as it is cleaved from its targets by the UFM1-specific pro-
tease, UFSP2 [reviewed in (3)].
Genetic studies using knockout (KO) mouse models and the 
identification of patients with mutations in the UFM1 pathway pro-
vided strong evidence for the indispensable role of this posttransla-
tional modification in animal development and homeostasis. It has 
been shown that UFM1 is crucial for hematopoiesis (4–6), liver de-
velopment (7), brain development (8), heart failure protection (9), 
maintenance of intestinal homeostasis, and protection from inflam-
matory diseases (10).
The nuclear receptor coactivator ASC1 (Activating signal cointe-
grator 1) was one of the first UFMylated proteins to be identified. 
UFMylated ASC1 enhances the recruitment of transcription cofactors 
to promoters of estrogen receptor  (ER) target genes to up-regulate 
their expression (11). More recently, it has been suggested that the 
ribosomal subunit RPL26 is the primary target of UFMylation with 
its UFMylation suggested to mediate ER homeostasis by regulating 
biogenesis of secretory proteins (12). In addition, up-regulation of 
protein levels of p53 and its targets and increased level of H2AX 
phosphorylation were recently reported in Ufl1-deficient bone mar-
row cells (5). This suggests that the UFM1 pathway could contribute 
to genome stability, although the exact mechanism whereby UFL1 
exerts this function remains unknown. Very recently, it was reported 
that UFM1 promotes ataxia-telangiectasia mutated (ATM) activa-
tion and mono-UFMylates histone H4 in response to double-strand 
breaks, suggesting that H4 UFMylation contributes to the amplifica-
tion of ATM activation (13).
In this study, we analyzed the functions of UFMylation in hema-
topoiesis by generating Ufm1- and Ufl1-deficient zebrafish. Our work 
reveals a hitherto unanticipated role for UFMylation in maintaining 
telomere length. We further define the underlying mechanism by 
identifying that UFMylated MRE11 recruits PP1- that dephosphoryl-
ates NBS1 to allow the recruitment of the MRN complex to telomeres. 
Consistent with this result, loss of UFMylation resulted in telomere 
leading-strand shortening, marked shortening of telomeres during 
hematopoiesis, and premature aging. These findings provide a likely 
explanation for the observed anemia in mice lacking components of 
the UFM1 pathway.
RESULTS
Inactivation of the Ufm1 pathway leads to hematopoietic 
stem and progenitor cell death and premature aging 
in zebrafish
As UFM1 has been shown to be crucial for hematopoiesis in mouse 
models (4–6), we investigated the relevance of UFMylation in zebrafish 
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using the unique advantages of this model for genetic analysis of 
hematopoiesis. As in mammals, zebrafish hematopoiesis occurs in 
two waves: The primitive wave generates a transient population of 
blood cells, while the second wave generates hematopoietic stem 
cells (HSCs) about 30 hours after fertilization (14). In the zebrafish 
line Tg(lcr:eGFP) that expresses green fluorescent protein (GFP) in 
erythroid cells (15), genetic inactivation of either ufm1 or ufl1 with 
CRISPR-Cas9 gene editing (fig. S1, A and B) resulted in reduced 
erythrocyte numbers in larvae at 4 days post-fertilization (dpf) 
(Fig. 1A, A′).
We then analyzed the emergence, maintenance, and differentia-
tion of HSCs using Tg(runx1:nfsB-mCherry) and Tg(mpx:eGFP) 
lines that fluorescently mark hematopoietic stem and progenitor 
cells (HSPCs) (16) and neutrophils (17), respectively. Using these 
models, we found that HSPC survival was impaired in Ufm1- 
and Ufl1-deficient F0 larvae, since a decreased number of HSPCs 
(Fig. 1B, B′) and neutrophils (Fig. 1C, C′) was observed at 5 dpf in 
the kidney marrow, the definitive hematopoietic tissue in zebrafish. 
However, the emergence of HSPCs (fig. S1C) and primitive myelo-
poiesis (fig. S1D) were both unaffected.
Although Ufm1- and Ufl1-deficient F0 embryo/larvae did not 
show any obvious defect during the first week of life (Fig. 1D), 40% 
of them displayed a broad collection of phenotypes 1 month after 
birth, including reduced size, curved tail, and cachexia (Fig.  1E). 
These phenotypes were observed in both males and females. Over-
all, the alterations observed in 3-month-old Ufm1- or Ufl1-deficient 
zebrafish resemble those normally observed in an aged 18-month-
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Fig. 1. UFM1 pathway prevents premature aging and telomere shortening. Tg(lcr:eGFP) (A), Tg(runx1:GAL4; UAS:nfsb-mCherry) (B), and Tg(mpx:eGFP) (C) one-cell 
embryos were injected with standard control (Std), ufm1, or ufl1 sgRNA and recombinant Cas9. Representative images of green and red channel of whole larvae for the 
different treatments (C′) and quantitation of erythroid cells at 4 dpf (A′), HSPCs (B′) and neutrophils cells at 5 dpf are shown. White arrows indicated HSPCs in the kidney 
marrow of 5-dpf larvae (B). Each dot represents normalized fluorescence from a single larva, while the mean ± SEM for each group is also shown. A representative image 
of control and deficient ufm1 or ufl1 larval phenotype at 1-week- and 1-month-old fish is shown (D and E). Phenotypic characteristics of 3-month-old fish deficient in Ufm1 
and Ufl1 are displayed with an old and young zebrafish. Larval survival curve (Kaplan-Meier representation) of genotype Ufm1- and Ufl1-deficient zebrafish compared with 
std. (F) Photo credit: Elena Martinez Balsalobre. Survival curve of fish deficient in Ufm1 and Ufl1. (G). Telomere length was determined by quantitative polymerase chain 
reaction (qPCR) in sorted erythroid cells (GFP−) (H) or (GFP+) (I) of 6-dpf larvae. Telomere was determined by quantitative fluorescence in situ hybridization (qFISH) in GFP+ 
cells (J). The data are shown as the means ± SEM of two independent experiments. **P < 0.01; ***P < 0.001; ****P < 0.0001 according to Student’s t test and analysis of 
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had a shortened life span, with approximately 60% dying before 
13 dpf and only 10 to 20% reaching 3 months of age (Fig. 1G).
The UFM1 pathway is required to maintain telomere length 
in zebrafish HSPCs
Telomeres are essential for genomic stability as they protect chro-
mosomes ends. In the absence of special telomere maintenance 
mechanisms, linear chromosomes shorten with every round of 
DNA replication, leading to replicative senescence, making telomere 
shortening one of the hallmarks of cell aging (18, 19). Intriguingly, 
despite the premature aging of Ufm1- and Ufl1-deficient zebrafish, 
we were not able to detect significant changes in telomere length by 
quantitative polymerase chain reaction (qPCR) analysis of whole 
zebrafish larvae at 6 dpf (Fig. 1H). Since this analysis is on a mixture 
of cell types, we next sought to determine whether telomere length 
was impaired in HSPCs. As larvae have low numbers of HSPCs, it is 
technically challenging to analyze telomere length in these cells. We 
therefore measured telomere length in erythrocytes, which, unlike 
human and mice, are nucleated, and this revealed that telomere 
length is reduced (Fig. 1, I and J). The telomere shortening observed 
in Ufm1- and Ufl1-deficient HSPCs is similar to the shortening in 
HSPCs of telomerase (tert and terc)–deficient zebrafish larvae (20). 
We therefore measured telomere length in erythrocytes as a surro-
gate of HSPCs. When telomere length was assayed by qPCR or 
quantitative fluorescence in situ hybridization (qFISH), we find robust 
telomere shortening in both Ufm1- and Ufl1-deficient erythrocytes 
compared to wild type (WT) (Fig. 1, I and J).
To determine whether premature aging observed in Ufl1- and 
Ufm1-deficient zebrafish was due to telomere attrition, we analyzed 
genetic epistasis between ufl1 (or ufm1) and tert. Notably, genetic 
inactivation of ufl1 or ufm1 Tert-deficient G1 (obtained from tert−/− 
G0) zebrafish larvae resulted in impaired development and drastic 
reduction of their life span (fig. S1, E and F). This cumulative effect 
suggests that the premature aging phenotype observed in Ufm1- and 
Ufl1-deficient zebrafish resulted from telomere attrition but was 
not due to telomerase inactivation.
Loss of UFL1 results in sister chromatid fusions
To get better insights into the underlying mechanism by which loss 
of UFMylation leads to telomere attrition and whether this is con-
served in human cells, we used CRISPR-Cas9–mediated genome 
editing to disrupt the UFL1 gene in HeLa cells (fig. S2, A to C). 
Analysis of genomic DNA from clonal populations of HeLa cells 
obtained using a guide RNA (gRNA) targeting exon 2 revealed a 
deletion and frameshift in both alleles confirming KO (fig. S2D). 
Consistent with published results (5), we noticed that UFL1 KO cells 
have a reduced growth rate [23.1 hours/per division (PD)] compared 
to parental HeLa cells (26.6 hours/PD) (fig. S2E). However, we did 
not observe any significant differences in cell cycle in the UFL1 KO cells 
(fig. S2F). Because telomere shortening can lead to chromosomal 
fusions, we next investigated whether UFL1 KO cells exhibited 
chromosome abnormalities. Metaphase chromosome spread experi-
ments revealed that UFL1 KO cells displayed a threefold increase in 
levels of spontaneous chromosomal fusions compared to WT HeLa 
cells (Fig. 2, A and B). We then assessed the effect of UFL1 inactivation 
on telomere fusions by using FISH on metaphase chromosome spreads. 
This approach revealed that most of the chromosomal fusions 
appear to be sister chromatid fusions (Fig. 2C). We also detected 
four times more chromatid ends with no detectable telomeric 
signal in UFL1 KO cells compared to WT HeLa cells (Fig. 2, D and E). 
Notably, most of these losses in telomeric signal appeared to be 
oriented, suggesting loss of either lagging or leading telomere strands 
(Fig. 2D, arrow).
UFL1 KO cells predominantly lose the  
leading-strand telomere
To next visualize telomeres produced by the lagging- and leading- 
strand synthesis, we used Chromosome Orientation (CO)–FISH. 
Using this approach, we detected that the loss of the leading telo-
mere signal was roughly three times more frequent than the loss of 
the lagging telomeric signal in UFL1 KO cells (Fig. 2, F and G). To 
determine whether UFL1 inactivation affected overall telomere 
length, we performed Southern blot analysis of terminal restriction 
fragments (TRFs) using two independently derived UFL1 KO clones. 
Both clones showed around 30% decrease of the mean telomere 
length compared to the WT controls (Fig. 2H). Together, these re-
sults suggest that UFL1 is required to maintain telomere length. To 
further characterize the changes in telomere length, we used the 
telomere shortest length assay (TeSLA) that reveals the length of 
individual telomeres from all chromosome ends (21). These analy-
ses showed that the fraction of very short telomeres (<1 kb) is in-
creased more than twofold in UFL1 KO compared to WT HeLa 
cells (Fig. 2, I and J, and fig. S3, A and B). The TeSLA analysis also 
revealed up to 40% reduction in the average length of amplified 
telomeres in UFL1 KO clones, further confirming an unappreciated 
role for UFL1 in telomere length regulation.
To rule out that the telomere shortening observed in UFL1 KO 
cells was due to loss of telomerase, we measured telomerase activity 
in HeLa extracts using the Telomere Repeated Amplification Proto-
col (TRAP) assay. No significant differences in telomerase activity 
between WT and UFL1 KO cells were detected (fig. S3C), indicating 
that loss of UFL1 does not appear to impair telomerase activity per 
se. Last, the labeling of H2AX at telomeres did not show any differ-
ences in the frequency of TIFs (Telomere dysfunction Induced Foci) 
between WT and KO (fig. S3D). In summary, these experiments 
suggest a role for UFMylation in telomere maintenance.
UFL1 localizes to telomeres
A role of UFL1 and UFMylation in maintaining telomere length 
suggests nuclear localization of the proteins. While UFM1 was ini-
tially detected within the nucleus (2), UFL1 has been described as a 
protein localized in the endoplasmic reticulum (ER) via its interac-
tion with the ER-resident protein UFBP1 (22). We therefore inves-
tigated the localization of endogenous UFL1 and UFM1 using cell 
fractionation of HeLa cells. In these assays, we detected UFL1 in the 
cytoplasmic (CET), nuclear (NEB), and chromatin (NEB+) frac-
tions. In contrast, free (unconjugated) UFM1 appeared to be pre-
dominantly cytoplasmic, while UFMylated proteins were detected 
in the nucleus and chromatin (fig. S4A). We also analyzed the local-
ization of UFM1 and UFL1 by expressing GFP-tagged forms of 
these proteins, which revealed both proteins to localize in the cyto-
plasm and the nucleus. When we use conditions that remove the 
proteins not bound to chromatin proteins (CSK buffer), we find 
UFM1 and UFL1 to form nuclear foci (fig. S4B). Monitoring colo-
calization between endogenous UFL1 and telomeres revealed that a 
fraction of UFL1 foci colocalized with telomeres (fig. S4C), suggest-
ing that the telomeric phenotypes of UFL1 KO cells may be a direct 
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MRE11 interacts with the UFM1 pathway members
To understand how UFL1 regulates telomere length, we sought to 
identify interactors of UFL1. Identification of enzyme partners has 
often been problematic because of the transient nature of the inter-
action, making it difficult to purify complexes by conventional pro-
tein coimmunoprecipitation methods. To overcome this issue, we 
used proximity labeling using the BioID method that biotinylates 
proteins in close vicinity (23). Biotinylated proteins can then be 
purified using streptavidin affinity capture and identified by mass 
spectrometry. To identify substrates and interactors of the UFM1 
E3 ligase UFL1, we fused BirA (R118G) biotin ligase domain to the 
N terminus of UFL1 (Fig. 3A) (23). Expression of the BirA-UFL1 
fusion protein can be induced in HeLa FRT-TREx cells. We first 
verified that the fusion of BirA on UFL1 did not alter the interaction 
of UFL1 with its known partner UFSP2. As expected, UFSP2 is only 
detected in the biotin pull-down from BirA-UFL1–expressing cells 
(Fig. 3B). After this validation, we performed mass spectrometry to 
identify proteins that were biotinylated by the BirA-UFL1 fusion. 
Proteins unique to the BirA-UFL1 pull-down and not detected in the 
BirA-GFP pull-down were considered for further analysis (table S1). 
Our mass spectrometry identified known partners of UFL1 such as 
UFBP1 and UFSP2, giving us confidence in the approach (Fig. 3C).
Using this approach, we identified MRE11 as a high confidence 
protein biotinylated by BirA-UFL1 (Fig. 3C). To validate this obser-
vation, we performed biotinylation experiments using cells express-
ing BirA-UFM1 or BirA-UFC1, which reveals that MRE11 is also an 
interactor of UFM1 and UFC1 (fig. S5, A, B, D, and E). We further 
confirmed the presence of MRE11 in biotin pull-down from BirA- 
UFL1 (Fig. 3D)– and BirA-UFM1–expressing cells by immunoblot-
ting (Fig. 3E).
MRE11 is a substrate of UFL1
MRE11 together with RAD50 and Nijmegen breakage syndrome 1 
(NBS1; also known as nibrin) forms the multifunctional protein 
complex MRN. Besides its role in the maintenance of genome sta-
bility (24), MRN promotes C-NHEJ at dysfunctional telomeres 
UFL1–/–WTA
H
































M 1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9 M
252                        342
3.12 kb                  2.12 kb
9.92 %                   24.56 %


































































































































































N (nb of bands)
Average length
Fraction below 1.0 kb
Shortest 20 % threshold
J
Fig. 2. UFL1 KO cells have defect in telomere length. (A) Representative image of chromosome metaphase spreads from WT and UFL1−/− cells. Black arrow: telomere 
fusion. (B) Quantification of the chromosomes breaks and fusions. (C) Quantification of the types of fusions. (D) Representative images of telomere FISH on metaphase 
spreads in HeLa and HeLa UFL1−/− cells. Blue, 4′,6-diamidino-2-phenylindole(DAPI)–stained chromosomes. Red dots, telomeres; white arrows, telomere loss. (E) Quantification 
of (D). (F) Representative image of CO-FISH labeling. (G) Quantification of the leading and lagging telomere losses. (H) Southern blot analysis of the terminal restriction 
fragment (TRF) lengths in indicated cells. Red lines indicate the peak signal intensity of the TRF smears. (I) Analysis of the individual telomere length distribution by telomere 
shortest length assay (TeSLA). Nine TeSLA PCRs were performed for each DNA sample. (J) Quantification of the TeSLA band distributions. *P < 0.1; **P < 0.01; ***P < 0.001; 
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through the activation of ATM (25–27). Last, the MRN complex 
has been proposed to regulate telomere length (6, 28). Given the 
biotinylation of MRE11 by BirA fusions of UFL1, UFM1, and 
UFC1, we therefore hypothesized that the UFM1 pathway may reg-
ulate telomere length via its interaction with the MRN complex.
We first investigated whether MRE11 could be UFMylated by 
UFL1  in an in  vitro UFMylation reaction. When recombinant 
MRE11 was added into the reaction, we detected a band shift of 
~10 kDa corresponding to the addition of a single UFM1 (Fig. 4A). 
This modification is dependent on the presence of UFL1, suggesting 
that MRE11 is a substrate of UFL1 (Fig. 4A). To test whether MRE11 
is also UFMylated in vivo, we analyzed cell extracts from HeLa cells 
with an Mre11 antibody. In accordance with the in vitro reconstitu-
tion results, a similarly shifted band of MRE11 was detected in ex-
tracts prepared from WT cells but not UFL1-deficient cells (Fig. 4B). 
While UFL1 is known to only mediate the attachment of UFM1 to 
proteins, we cannot rule out that the observed loss of modified 
MRE11 in UFL1 KO cells could be an indirect effect of MRE11 be-
ing modified by a different PTM. To confirm that the higher 
molecular weight band of MRE11 detected is indeed UFMylated 
MRE11, we incubated the protein extracts from WT cells with re-
combinant UFSP2. Incubation with UFSP2 results in the dis-
appearance of the slower-migrating band, confirming that the 
observed band is UFMylated MRE11 (Fig. 4B). Together, these re-
sults demonstrate that UFL1 UFMylates MRE11 both in vitro and 
in cells.
We next sought to identify lysine residues in MRE11 that are 
UFMylated. Because MRE11 contains 45 lysine residues, we won-
dered whether we could define a consensus UFMylation site based 
on homology with identified UFMylation sites on ASC1 (Fig. 4C). 
Using this approach, we identified four lysine candidates within two 
stretches of MRE11 (K196-K197 and K281-K282). To test whether 
these lysines in MRE11 are the preferred UFMylation sites, we mu-
tated each pair to arginine. Whereas mutation of the K196-K197 or 
K281-K282 lysines into arginines did not affect the UFMylation of 
MRE11 in vitro (Fig. 4D), mutating K281R-K282R led to a strong 
reduction of UFMylation in HeLa cells (Fig. 4E). This result sug-
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Fig. 3. UFL1 interacts with MRE11. (A) Strategy for the identification of UFL1 binding proteins. (B) Biotinylated proteins are purified from cells expressing BirA-GFP or 
BirA-UFL1. The samples were then subjected to immunoblot with indicated antibodies. (C) List of the candidate target proteins identified by mass spectrometry. 
(D) Biotinylated proteins are purified from cells expressing BirA-GFP or BirA-UFL1. The samples were then subjected to immunoblot with indicated antibodies. (E) Biotinylated 
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UFL1 does not regulate DSB repair
MRE11 is part of the MRN complex, a sensor of DSBs that controls 
the DNA damage response (DDR) by governing the activation of 
the central transducing kinase ATM. In addition, MRN regulates 
DSB repair through the homology directed repair (HDR) pathway 
(29). We thus investigated whether UFL1 could control DSB repair 
by monitoring the activation of ATM and ATR as well as the phos-
phorylation of H2AX upon DNA damage. Compared to WT cells, 
phosphorylation of ATR, ATM (fig. S6A), and H2AX (fig. S6B) was 
slightly enhanced in UFL1 KO cells exposed to various DNA dam-
aging agents. However, contrary to recently published results (30), 
we do not find the sensitivity of UFL1 KO cells to x-rays to be sig-
nificantly increased compared to control cells (fig. S6C). Moreover, 
a GFP reporter assay of DNA repair indicated that HDR was not 
compromised in UFL1 KO cells (fig. S6D). In summary, these re-
sults demonstrate that UFL1 does not play a critical role in DSB re-
pair and HDR.
To further characterize the regulation of MRN by UFL1 upon IR 
stress, we performed MRE11 immunoprecipitation from chromatin 
fractions of cells exposed to IR. These experiments revealed that the 
MRN complex formation is not affected in UFL1 KO cells (fig. S6E). 
In addition, we did not observe differences in the amount of UFL1 
associated with MRE11 after induction of DSB by irradiation (fig. 
S5E). These results are in agreement with our mass spectrometry 
analysis of the proteins interacting with UFM1 (fig. S5, A, D, and E), 
UFC1 (fig. S5, B, D, and E), and UFL1 (fig. S5, C to E). Exposure of 
cells to IR did not increase the biotinylation of MRE11. This indi-
cates that the interaction between MRE11 and components of the 
UFM1 pathway is not increased upon DNA damage.
UFL1 regulates the interaction of MRE11 and NBS1 
with telomeres
It has been shown that the recruitment of MRN to telomeres is me-
diated by the direct interaction between NBS1 and the shelterin 
protein TRF2 (31). To evaluate whether the recruitment of MRN to 
telomeres was impaired in UFL1 KO cells, we quantified the colo-
calization between endogenous MRE11 and telomeres by fluorescence 
microscopy. This approach revealed a reduction in colocalization of 
MRE11 with the telomeric probe in UFL1 KO cells (Fig. 5, A and B). 
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Fig. 4. MRE11 is UFMylated on K281-282. (A) Recombinant His6-MRE11 were incubated with UFMylation enzymes and UFM1 in the presence of adenosine triphosphate 
and MgCl2 for 1 hour at 37°C. The reaction was stopped by the addition of 3× SDS loading buffer, and the reaction products were separated on a 4 to 12% NuPAGE SDS–
polyacrylamide gel electrophoresis (SDS-PAGE) gel. Top: Western blot analysis of UFMylation of MRE11 WT and mutants using MRE11-specific antibody. Bottom: 
Ponceau-stained nitrocellulose blot as loading control. (B) Cells (106) are lysed in SDS, and after treatment or not with recombinant UFSP2, samples were subjected to 
immunoblot with indicated antibodies. (C) Protein alignment of ASC1 UFMylated site with MRE11 sequence. (D) Same as (A) with MRE11 fragment mutated in indicated 
residues. (E) GFP-tagged MRE11 WT and mutant were expressed in cells with 6HIS-UFM1 as indicated. Cell lysates were subjected to pull-down with NTA resins followed 
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Lane 1 Lane 2 Lane 3 Lane 4
Fig. 5. UFL1 regulates the interaction of MRE11 and NBS1 with telomeres. (A) Colocalization of MRE11 (MRE11 antibodies) and telomere (telomere probe) in the in-
dicated cells. (B) Quantification of (A). (C) Protein lysates from the indicated cells were subjected to MRE11 immunoprecipitation. Immunoprecipitation with immuno-
globulin G (IgG) was used as a negative control. After SDS-PAGE, samples were analyzed with the indicated antibodies. (D) GFP-tagged MRE11 WT and mutant were 
expressed in cells as indicated. Cell lysates were subjected to GFP TRAP followed by immunoblot with the indicated antibodies. (E) Protein lysates from the indicated cells 
were subjected to TRF2 or NBS1 immunoprecipitation. Immunoprecipitation with IgG was used as a negative control. After SDS-PAGE, samples were analyzed with the 
indicated antibodies. (F) NBS1 immunoprecipitation from WT or UFL1−/− cells were incubated with phosphatase or heat-inactivated phosphatase before Western blot 
analysis of NBS1. Intensities of the band along the indicated red line were quantified using Fiji and are represented on the graphs. (G) Same as (D). (H) Protein lysates from 
the indicated cells overexpressing Flag-Apollo were subjected to Flag or TRF2 immunoprecipitation. Immunoprecipitation with IgG was used as a negative control. After 
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regulated by UFMylation, we performed immunoprecipitation of 
MRE11 from WT and UFL1 KO cells. While similar amounts of 
RAD50 coprecipitated with MRE11 in UFL1 KO and control cells, 
MRE11 association with TRF2 was strongly reduced in the absence 
of UFL1 (Fig. 5C). Collectively, these results indicate that the re-
cruitment of MRE11 to telomeres is markedly reduced when UFL1 
is inactivated, suggesting that UFMylation of MRE11 regulates its 
localization to telomere. To confirm that UFMylation of MRE11 is 
necessary for its interaction with telomeres, we expressed GFP-
tagged MRE11 and mutants that cannot be UFMylated in HeLa 
cells and tested their association with endogenous TRF2. Whereas 
TRF2 coimmuno precipitated with GFP-MRE11 and GFP-MRE11-
K196-7R, it was barely coimmunoprecipitated with the UFMylation 
defective GFP-MRE11 K281-2R mutant. This mutant retained the 
ability to bind RAD50, confirming that mutating these lysines does 
not disrupt MRE11 folding (Fig. 5D). Together, these results sug-
gest that UFL1 promotes localization of MRE11 at telomeres.
Since MRE11 interacts with NBS1, which, in turn, interacts with 
TRF2 (31), we performed NBS1 and TRF2 coimmunoprecipitation 
to determine whether the interaction between NBS1 and TRF2 was 
impaired in UFL1 KO cells. As shown in Fig.  5E, the interaction 
between NBS1 and TRF2 was reduced in UFL1 KO cells, implying 
that the impaired recruitment of MRE11 to telomeres in UFL1 KO 
cells is a consequence of the reduced interaction between NBS1 
and TRF2.
Dephosphorylation of NBS1 by PP1- is regulated by UFL1
In these experiments, we noticed that the NBS1 protein from UFL1 
KO cells appears to migrate as a slightly higher molecular weight 
form compared to parental cells (Fig. 5E). Such a size shift is remi-
niscent of phosphorylation. To test whether the size shift of NBS1 in 
UFL1 KO cells was due to phosphorylation, we incubated the NBS1 
immunoprecipitation with alkaline phosphatase, which revealed that 
treatment with active phosphatase and not heat-inactivated phos-
phatase resulted in the disappearance of the slower-migrating form 
(Fig. 5F). Furthermore, the level of phospho-NBS1 is increased 
in UFL1 KO cells, suggesting that UFL1 might indirectly regulate 
NBS1 phosphorylation. Phosphorylation inhibits NBS1 binding to 
TRF2, and the phosphatase PP1- was reported to dephosphorylate 
NBS1, thereby promoting NBS1-TRF2 interaction (31). PP1- was 
among the high-confidence proteins biotinylated by BirA-UFL1 
identified by mass spectrometry (table S1). We therefore hypothe-
sized that the activity of PP1- might be modulated by UFL1. We 
first examined the interaction of PP1- with MRE11 by performing 
purification of GFP-MRE11. We find that the association of PP1- 
with GFP-MRE11 appeared to be mildly reduced when the lysines 
that undergo UFMylation are mutated in MRE11 (Fig. 5G). We infer 
from this result that MRE11 UFMylation promotes the interaction 
between PP1- and the MRN complex, resulting in the dephos-
phorylation of NBS1 to promote NBS1 interaction with TRF2.
The Apollo/SNM1B nuclease functions together with TRF2 to 
protect telomeres (32) and phosphorylation of NBS1 dissociates 
NBS1 from TRF2 to promote TRF2-Apollo/SNM1B interaction 
(31). Since NBS1 phosphorylation is increased in UFL1 KO cells, we 
asked whether recruitment of Apollo/SNM1B to telomeres was im-
paired in UFL1 KO cells. We find that the amount of Flag-Apollo/
SNM1B coimmunoprecipitated with TRF2 was increased in UFL1 KO 
cells. This result suggests that the balance between dephosphorylated 
NBS1 and Apollo/SNM1B is regulated by UFL1 (Fig. 5H).
UFMylation of MRE11 prevents premature aging 
and telomere shortening in zebrafish
On the basis of the results obtained in human cells, and in zebrafish, 
we tested whether mre11a and its UFMylation is also critical for 
telomere maintenance and hematopoiesis in zebrafish. We first 
demonstrated that genetic inactivation of mre11a by CRISPR-Cas9 
resulted in decreased erythrocyte numbers in 4-dpf larvae (Fig. 6A, A′) 
and telomere shortening in erythrocytes (Fig. 6, B, B′, and C). No-
tably, anemia (Fig. 6A, A′) and telomere attrition (Fig. 6, B, B′, and C) 
of Mre11a-deficient larvae were both rescued by the forced expres-
sion of WT Mre11a but not of the K283R mutant (which is equiva-
lent to K282 of human MRE11). Like Ufm1- and Ufl1-deficient 
zebrafish, Mre11a-deficient larvae showed reduced life span (Fig. 6D) 
and impaired development observed from 1 month onward (Fig. 6E). 
Furthermore, genetic inactivation of mre11a in Tert-deficient larvae 
resulted in marked impaired development and further reduced 
life span (Fig. 6, F and G). Together, these results suggest that 
disrupting the UFMylation of MRE11 in a vertebrate animal mod-
el results in telomere attrition in vivo, with severe consequences 
for development likely probably due to telomere shortening in 
stem cells.
DISCUSSION
Our work reveals a new role for the UFM1 pathway in maintaining 
telomere length and preventing premature aging in zebrafish. In 
human cells, loss of UFL1 results in sister chromatid fusion and the 
preferential loss of the leading-strand telomere. The fact that UFL1 
can be localized at telomeres prompted us to focus on interactors of 
UFM1 E3 ligase UFL1 related to telomere length maintenance. We 
uncover that MRE11 is UFMylated and that this modification regu-
lates MRE11 association with telomeres, which have previously been 
shown to interact with TRF2 (33). The question that arises is whether 
the lack of MRE11 UFMylation is the cause of the telomeric pheno-
types observed in UFL1 KO cells.
The role of MRE11 at telomeres was mainly demonstrated at un-
capped telomeres (25–27, 34). In cells lacking TRF2, MRE11 re-
moves the 3′ telomeric overhang to promote chromosome fusions. 
At normal telomeres in telomerase-positive cells, the MRN complex 
was shown to play a role in the generation of G-overhangs at human 
telomeres (35). More recently, CDK2-mediated phosphorylation of 
NBS1 was shown to regulate the interaction between TRF2 and 
NBS1 (31) and dephosphorylation of NBS1 by PP1- promotes its 
dissociation from TRF2, thereby facilitating TRF2-Apollo/SNM1B 
complex formation (31). Nucleolytic processing of telomeres and 
generation of 3′ overhangs are regulated by the concerted action of 
Apollo and Exo1 nucleases, and CST fill in (36, 37). We discovered 
that (i) PP1- is biotinylated by BirA-UFL1, (ii) PP1 interacts with 
MRE11  in a UFMylation-dependent manner, (iii) inactivation of 
UFL1 leads to the hyper-phosphorylation NBS1, and (iv) Apollo as-
sociation to telomeres is increased in UFL1-KO cells. Collectively, 
these findings suggest that UFMylation favors the dephosphoryla-
tion of NBS1 by PP1-, thereby promoting the release of the MRN 
complex from telomeres and the association of Apollo to TRF2. The 
fact that the UFMylation defective MRE11-K281-2R mutant does 
not interact with PP1- suggests that MRE11 UFMylation promotes 
the recruitment of PP1- to the MRN complex. The loss of PP1- 
recruitment by MRE11 stabilizes the phosphorylation of NBS1 and 
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Leading- and lagging-strand telomeres of mammalian cells be-
have differently. TRF2-deficient cells exhibit telomere-telomere fu-
sions specifically between leading-strand telomeres (38). In addition, 
inactivation of TRF2 combined with deletion of Mre11 biases fu-
sions to leading- rather than lagging-strand telomeres (26). A similar 
phenotype was also observed in cells expressing the hypomorphic 
Mre11 ATLD1 (25). Consistent with the model proposed in our 
study, we found that UFL1 inactivation leads to the preferential loss 
of the leading-strand telomere that may reflect the increased accessi-
bility of Apollo in particular at the leading telomere (36, 37). In yeast, 
Mre11 was shown to be specifically recruited at the leading telomere, 
thereby allowing the regeneration of the 3′ overhang (39). It is tempt-
ing to speculate that MRE11 UFMylation may control the telomere 
processing by regulating the access of Apollo at the leading telomere.
In light of the presented results, we propose a model where UFL1 
regulates telomere length in human cells by modifying MRE11. 
While we cannot rule out that UFL1 regulates other mechanisms 
involved in telomere maintenance, the reduction of telomere length 
observed in zebrafish deficient in MRE11 UFMylation supports a 
role of MRE11 and its UFMylation in telomere maintenance. The 
fact that MRE11 and its UFMylation affect telomere length in ze-
brafish may be in apparent contradiction with previous findings 
showing that no telomere shortening was observed in mouse em-
bryonic fibroblasts carrying the hypomorphic Mre11(ATLD1/ATLD1) 
mutation, even after extensive passage through culture (25). This 
paradox may be explained by the fact that the lack of MRE11 
UFMylation creates a gain of function by promoting a cell cycle de-
regulation of NBS1 phosphorylation whose effects would be distinct 
from a loss of function of MRE11. To our knowledge, telomere 
shortening in MRN-deficient vertebrates has not been reported yet. 
Here, we report an early premature aging phenotype that could be a 
consequence of a defect in telomere length maintenance in pluripo-
tent cells. Notably, telomere length analysis in zebrafish was carried 
out on erythrocyte cells as a read out for telomeres in pluripotent 
cells. Mouse pluripotent cells display a TRF2-independent mecha-
nism of telomere protection (40, 41). Our results in zebrafish sug-
gest that the UFM1 pathway could contribute to telomere maintenance 
essentially in stem cells during development. This could explain why 
humans carrying point mutations in genes of the UFM1 pathway dis-
play developmental defects (8).
Our work reveals the UFM1 pathway as a new regulator involved 
in telomere maintenance in zebrafish and humans. Patients mutat-
ed in UFM1 display brain development defects. Whether the func-
tion of UFM1 in telomere maintenance plays a role in preventing 
these defects remains to be investigated.
MATERIALS AND METHODS
Cell culture and transfection
293T and HeLa FRT-T-Rex (Invitrogen) were maintained at 37°C in 
DMEM (Dulbecco’s modified Eagle’s medium; Gibco) supplemented 
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Fig. 6. UFMylation of MRE11 prevents premature aging and telomeres shortening in zebrafish. (A and A′) Tg(lcr:eGFP) one-cell embryos were injected with standard control 
(Std) or mre11a sgRNA recombinant Cas9 and complemented with the indicated mRNA. Representative images of green channel of whole larvae for the different treatments and 
quantitation of erythroid cells at 4 dpf. Each dot represents normalized fluorescence from a single larva, while the mean ± SEM for each group is also shown. (B) Telomere length 
was determined in GFP+ cells by qFISH (B and B′) or qPCR (C). Larval survival curve (Kaplan-Meier representation) of genotype mre11a- deficient zebrafish compared with std 
(D). Representative images of control and deficient mre11a larval phenotype at 1-week- and 1-month-old fish are shown (E). Representative images of Tert-deficient larvae injected 
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(Gibco). For transfection, each dish of adherent cells was transfected 
with 5 to 10 g of plasmid DNA using Lipofectamine 2000 (Thermo 
Fisher Scientific). Flag Apollo was a gift of P. Revy (42).
CRISPR gene editing
CRISPR-Cas9 px335 and pBabe-U6 have been used to clone gRNA 
sense and antisense, respectively. Cloning has been made according 
to Zhang laboratory protocols. Cells have been transfected with 1 g 
of combined plasmids and cell-sorted into 96-well plates. Clones have 
been screened using immunodetection of targeted proteins, and the 
mutation has been sequenced as described before (43).
Stable cell line establishment
Stable cells expressing BirA-GFP or BirA-tagged proteins were 
generated according to the manufacturer’s instructions. Briefly, 
pcDNA5 FRT BirA plasmids were cotransfected with POG44 plas-
mids (ratio 1/9) with Lipofectamine 2000 (Invitrogen). Cells were 
then selected with hygromycin and blasticidin.
Cloning
Restriction enzyme digestions, DNA ligations, and other recombi-
nant DNA procedures were performed using standard protocols. 
All mutagenesis was performed using the QuikChange site-directed 
mutagenesis method (Stratagene) with KOD polymerase (Novagen). 
All DNA constructs were verified by DNA sequencing, which was 
performed by GATC (Eurofins). DNA for mammalian cell transfec-
tion was amplified in Escherichia coli DH5 strain, and plasmid 
preparation was done using QIAGEN Maxi prep kit according to 
the manufacturer’s protocol.
Biotin ligase assay
Expression of BirA proteins was induced for 24 hours by adding 
1 M doxycycline (Sigma-Aldrich). For purification of biotinylated 
substrates, 10 cm by 10 cm dishes were treated for 8 hours with 50 M 
biotin. Cells were then collected, washed with phosphate- buffered 
saline (PBS), and resuspended in lysis buffer [0.5 ml/10 cm dish; 8 M 
urea, 1% SDS, 50 mM N-ethylmaleimide, 1× protease inhibitor cock-
tail (Roche) in PBS]. Sonication was performed as needed to reduce 
sample viscosity. To reduce urea concentration, the samples were 
diluted by adding binding buffer (3 M urea, 1 M NaCl, and 0.25% 
SDS; 0.5 volume). Incubation was done using 100-l suspension of 
high-capacity Streptavidin-Sepharose beads (GE Healthcare) over-
night at room temperature. Washes have been done with 2× WB1, 
3× WB2, 1× WB3, 3× WB4, 1× WB1, 1× WB5, and 3× WB6 [WB1: 
8 M urea, 0.25% SDS in PBS; WB2: 6 M guanidine hydrochloride in 
PBS; WB3: 6.4 M urea, 1 M NaCl, 0.2% SDS in PBS (prewarmed to 
37°C); WB4: 4 M urea, 1 M NaCl, 10% isopropanol, 10% ethanol, 
0.2% SDS in PBS; WB5: 8 M urea, 1% SDS in PBS; WB6: 2% SDS in 
PBS]. Samples were eluted in 100 l of 4× Laemmli sample buffer 
with 100 mM dithiothreitol (DTT) by two cycles of heating (5 min; 
99°C), with vortexing in between. For mass spectrometry analysis, 
the bead slurry was transferred to a Vivaclear Mini 0.8-m PES 
filter (Sartorius) and spun to recover bead-free eluate.
Mass spectrometry
Pull-down elutions were separated by SDS–polyacrylamide gel electro-
phoresis (SDS-PAGE) and stained with Brilliant Blue G-Colloidal 
Concentrate (Sigma-Aldrich) according to the manufacturer’s 
instructions. Gel bands were excised from the whole gel lane and 
destained, and proteins were in-gel digested with trypsin (sequenc-
ing grade, Promega) overnight. The resulting peptide mixtures were 
analyzed by liquid chromatography (LC)–tandem mass spectrometry 
using Orbitrap Fusion Lumos Tribrid Mass Spectrometer (Thermo 
Electron, Bremen, Germany) online with a nanoLC Ultimate 3000 
chromatography system (Dionex, Sunnyvale, CA) through an LC 
EASY-Spray C18 column from Dionex. All raw LC–mass spectrom-
etry files were processed with MaxQuant software (version 1.5.3.8, 
www.maxquant.org) and searched against species-specific UniProt 
protein sequence databases and common contaminants using the 
Andromeda peptide search engine with a false discovery rate of 0.01 
at both peptide and protein levels.
The lists of proteins identified by mass spectrometry were ana-
lyzed as follows. First, contaminants and proteins identified by only 
one peptide were eliminated. Then, only those proteins with at least 
10-fold higher peak surface in the experiment samples versus the 
controls BirA-GFP were considered as positive hits.
Protein extraction
Ten-centimeter dishes were resuspended with 300 l of lysis buffer 
[50 mM tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM 
EGTA, 1% (w/v) Triton, 1 mM sodium orthovanadate, 10 mM 
sodium glycerophosphate, 50 mM sodium fluoride, 10 mM sodium 
pyrophosphate, 0.27 M sucrose, 0.1% (v/v) 2-mercaptoethanol, 1 mM 
benzamidine, and 0.1 mM phenylmethylsulfonyl fluoride (PMSF)]. 
After a sonication of 2 min (Bioblock Vibracell) extracts were incu-
bated with 250 U of nuclease (Universal Nuclease Pierce) at 4°C for 
30 min, centrifuged at full speed, and quantified (BCA Protein Assay 
Kit, Pierce).
Immunobloting
For immunobloting, 30 g of total protein extracted or 25 l of pro-
tein fraction (subcellular protein fractionation kit, Thermo Fisher 
Scientific) has been separated by SDS-PAGE 4 to 12% (bis-tris Bolt, 
Thermo Fisher Scientific) and transferred on nitrocellulose (Turbo 
transfer Bio-Rad). The signal was detected with ChemiDoc (Bio-Rad). 
Larvae of 6 dpf were lysed in lysis buffer [50 mM tris-HCl (pH 7.5), 
1% IGEPAL, 150 mM NaCl, and a 1:20 dilution of the protease in-
hibitor cocktail P8340 from Sigma-Aldrich]. Samples were centri-
fuged (13,000g, 10 min) and resolved on 4 to 12% SDS-PAGE and 
transferred to polyvinylidene difluoride membranes. Membranes 
were blocked for 1 hour at room temperature and incubated over-
night at 4°C. For detection, corresponding horseradish peroxidase–
conjugated secondary antibodies (1:5000 dilution) were used. After 
repeated washes, the signal was detected with the enhanced chemi-
luminescence reagent and ChemiDoc XRS Bio-Rad.
Immunoprecipitation
For immunoprecipitation of GFP, TRAP-GFP beads were used. 
Lysates (0.5 to 5 mg) were incubated with 10 to 20 l of resin for 
2 hours at 4°C under gentle agitation, and the immunoprecipitates 
were washed three times with lysis buffer containing 0.15 M NaCl 
and then twice with lysis buffer. Proteins were eluted by resuspend-
ing washed immunoprecipitates in 30 l of 1× SDS sample buffer.
Immunofluorescence
Cells were washed with PBS and fixed for 10 min with 4% parafor-
maldehyde in PBS. Cells were permeabilized for 20 min with 
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(PBS-T) containing 5% bovine serum albumin (BSA). Coverslips 
were incubated for 1 hour with primary antibodies and for 1 hour 
with appropriate secondary antibodies coupled to Alexa Fluor 488 
or 594 fluorophores (Life Technologies), before being incubated with 
4′,6-diamidino-2-phenylindole (DAPI; 2 g/ml). Pictures were ac-
quired with Z1 (Zeiss). For high-resolution imaging, z-stacks were 
acquired with a Z1 (z-stack of 0.2-m interval) equipped with a 63× 
oil objective (ZEISS) and controlled with Zen. Deconvolutions were 
then performed in conservative mode. The different channels were 
acquired sequentially.
Bacterial protein purification
Recombinant His6-UBA5, His6-UFM1, His6-MRE11 WT, and 
mutants were expressed in E. coli BL21 and purified using Ni2+– 
nitrilotriacetic acid (NTA) affinity chromatography. Briefly, E. coli 
BL21 cultures expressing His6-tagged proteins were grown in 2xTY 
medium at 37°C until OD 0.6. Protein expression was induced with 
0.5 mM isopropyl--d-thiogalactopyranoside (IPTG), and the cul-
tures were incubated at 18°C for 16 hours. Cells were lysed in lysis 
buffer [25 mM tris 7.5, 300 mM NaCl, 10% glycerol, 2 mM DTT, 
1 mM benzamidine, 1 mM AEBSF, and protease inhibitor cocktails 
(Roche)]. Lysed cells were then clarified by centrifugation at 30,000g 
for 30 min at 4°C. The clarified lysate was then incubated with Ni2+-
NTA Agarose beads for 2 hours in binding buffer (25 mM tris 7.5, 
300 mM NaCl, 10% glycerol, and 10 mM imidazole), washed exten-
sively, and eluted using binding buffer containing 300 mM imidazole. 
His6-tags were then cleaved off by incubating tagged proteins with 
3C protease at 4°C overnight. E. coli BL21 culture was grown and 
induced using IPTG as described above. A two-step affinity enrich-
ment process was used to purify the UFL1 ligase complex. First, the 
clarified cell lysate was incubated with Ni2+-NTA Agarose beads for 
2 hours at 4°C in binding buffer containing 25 mM tris (pH 8.0), 300 mM 
NaCl, 2 mM DTT, and 10 mM imidazole. After washing the beads 
using binding buffer containing 20 mM imidazole, the protein was 
eluted using binding buffer containing 300 mM imidazole. In the 
second step, the eluted protein was passed through a StrepTrap (GE 
Healthcare Life Sciences) column and eluted using binding buffer 
containing 2.5 mM desthiobiotin. Last, the purified complex was 
passed through a Superdex 200 16/60 column (GE Healthcare Life 
Sciences) using buffer containing 25 mM tris (pH 8.0), 300 mM 
NaCl, and 2 mM DTT. The purified UFL1 ligase was stored in the 
same buffer at −80°C. Glutathione S-transferase (GST)–tagged Ufc1 
was expressed in E. coli BL21 as described above. Cells were lysed in 
lysis buffer containing 25 mM tris (pH 7.5), 300 mM NaCl, 10% glyc-
erol, and 2 mM DTT using ultrasonication. Glutathione B Sepharose 
beads were incubated with clarified lysate for 2 hours. The beads were 
then washed with high salt buffer containing 25 mM tris-HCl (pH 7.5), 
500 mM NaCl, 10% glycerol, and 1 mM DTT followed by low-salt 
buffer containing 25 mM tris-HCl (pH 7.5), 150 mM NaCl, 10% glyc-
erol, and 1 mM DTT. The GST tag was then cleaved off by incubation 
with C3 protease at 4°C overnight. All proteins were further purified 
by size exclusion chromatography using Superdex 75 16/60 and 
Superdex 200 16/60 columns (GE Healthcare Life Sciences). The 
purified proteins were then concentrated and stored at −80°C.
In vitro UFMylation assay
Recombinant fragments of MRE11 and mutants were incubated with 
0.25 M UBA5, 5 M UFC1, 2 M UFL1 ligase, and 30 M UFM1 in 
reaction buffer containing 50 mM Hepes (pH 7.5), 10 mM MgCl2, 
and 5 mM adenosine triphosphate for 1 hour at 37°C. The reaction 
was stopped by the addition of 3× SDS loading buffer containing 
10% mercaptoethanol. The reaction products were separated on a 
4 to 12% NuPAGE SDS-PAGE gel and analyzed by Immunoblotting 
using MRE11 antibody.
Cell sensitivity assay
For sensitivity assay to irradiation (IR), 1000 cells were plated in three 
replicates onto 10-cm plates in complete growth medium. After 
cells attached, they were treated with the indicated dose of IR. The 
number of colonies with >100 cells was counted. For each genotype, cell 
viability of untreated cells was defined as 100%. Data are represented 
as means ± SD from three independent experiments. For the other 
cytotoxicity assays, 1000 cells were plated in 96-well dishes. The 
next day, indicated drugs were added to the wells and plates were 
transferred into an IncuCyte microscope (Essen BioScience). Phase 
contrast pictures were acquired every 3 hours over 48 hours. Percentage 
of cell confluence was calculated by the Cell Player integrated software 
(Essen BioScience) and analyzed with GraphPad Prism software.
Homologous recombination assay
HeLa WT and HeLa UFL1 KO were transfected with 5 g of pCBA-
I-SceI and 5 g of DR-GFP. Twenty-four hours later, cells were 
harvested and analyzed by fluorescence-activated flow cytometry 
(FACS) to examine GFP-positive cells. Cells were gated to exclude 
cellular aggregates, debris, and GFP-negative cells in the FSC/FSC 
dot plot. Gates of positive cells were set and compared with a con-
trol sample (without pCBA-I-SceI). Results were normalized with 
transfection efficiency using mCherry plasmids.
Zebrafish experiments
For CRISPR experiments, zebrafish lines used were Tg(mpx:eGFP)i114 
(17), Tg(lcr:eGFP)cz3325 (14), Tg(runx1:GAL4)utn6 (16), and 
Tg(UAS:nfsB-mCherry)c264 (15). The single guide RNA (sgRNAs) 
were obtained from IDT and prepared using the manufacturer’s 
manual with a concentration of resulting duplex of ~1715 ng/l 
(50 M). After assembling the ribonucleoprotein complex, 1 nl of 
the mix was injected into the yolk of 1-cell stage zebrafish embryos. 
The sequences of the guides are ufm1 5′-TGAGAGCACACCAT-
TCACAG CGG-3′, ufl1 5′-CCC AGAGCACTTGGGTTGAGTCG-3′, 
mre11a 5′-GGCAACCATGATGACCCAAC TGG-3′.
WT (NM_001001407) and K283R Mre11a were synthesized by 
GenScript. In vitro–transcribed RNA was obtained using mMESSAGE 
mMACHINE kit (Ambion) following the manufacturer’s instructions 
and 100 pg per egg was microinjected in combination with Cas9 
ribonucleoprotein complex as indicated above.
Images were acquired at 3, 4, and 5 dpf using a Leica M205 FA 
fluorescence stereo microscope equipped with a DFC365FX camera 
(Leica) and processed using ImageJ software (http://rsb.info.nih.gov/ij/) 
and Photoshop CS.
Approximately 300 to 500 larvae were anesthetized in tricaine, 
minced with a razor blade, and incubated at 28°C for 30 min with 
Liberase (0.077 mg/ml; Roche), and the resulting cell suspension was 
passed through a 40-m cell strainer. Cell sorting was performed on a 
SH800Z Cell Sorter (Sony). The experiments performed comply with 
the Guidelines of the European Union Council (Directive 2010/63/
EU) and the Spanish RD 53/2013. Experiments and procedures were 
performed as approved by the Bioethical Committee of the University 
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Telomere measurement by qPCR
Genomic DNA was extracted from the cells using the ChargeSwitch 
Genomic DNA Micro Tissue Kit (Invitrogen). The telomeric se-
quences were detected through real-time PCR using 16 ng of gDNA 
as a template. Ribosomal protein S11 (rps11) content in each sample 
was used for normalization of zebrafish mRNA expression, using the 
comparative Ct method (2-DCt). Actin and 36b4 were used as a stan-
dard value for lymphocytes and HeLa cell line, respectively. Reaction 
mixtures were incubated for 15 min at 95°C, followed by 40 cycles of 15 s 
at 95°C, 2 min at 54°C, and lastly 15 s at 95°C, 1 min at 60°C, and 15 s 
at 95°C. For the standard genes, reaction mixtures were incubated 
for 10 min at 95°C, followed by 40 cycles of 15 s at 95°C, 1 min at 
60°C, and lastly 15 s at 95°C, 1 min at 60°C, and 15 s at 95°C.
The primers used were as follows: Telom F: 5′-TTTTTGAGG-
GTGAGGGTGAGGGTGAGGGTGAGGGT-3′ and Telom 
R:  5′-TCCCGACTATCCCTATCCCTATCCCTATCCCTATC-
CCTA-3′; rps11 F: 5′-ACAGAAATGCCCCTTCACTG-3′ 
and rps11 R: 5′-GCCTCTTCTCAAAACGGTTG-3′; 36b4 F: 
5′-CAGCAAGTGGGAAGGTGTAATCC-3′ and 36b4 R: 5′-CCCATTC-
TATCATCAACGGGTACAA-3′; Actin F: 5′-GGCACCACACCTTC-
TACAATG-3′ and R: 5′-GTGGTGGTGAAGCTGTAGCC-3′.
The results were normalized with the control. In all cases, each 
PCR was performed with triplicate samples and repeated at least 
with two independent samples. The differences between two sam-
ples were analyzed by the Student’s t test and between three samples 
by one-way analysis of variance.
Metaphase spread analysis
Cells were initially plated in DMEM containing 10% FBS until cells 
reached 60 to 70% confluence. All cultures were harvested following 
the conventional cytogenetic protocol. Briefly, the cell cultures were 
treated with Colcemid (0.1 g/ml; Irvine Scientific) approximately 
30 min before the initiation of harvest. For chromosome preparations, 
the cells were harvested following the conventional cytogenetic proto-
col of hypotonic treatment (75 mM KCl) and freshly prepared chilled 
3:1 methanol:acetic acid fixation. This was followed by four additional 
fixation cycles and air-dried slide preparation. The slides were “aged” 
in a hot oven at 60°C over 16 hours, followed by Giemsa staining 
(Invitrogen). A total of 25 metaphases were scored for each culture.
Analysis of cell cycle by flow cytometry
Cells were analyzed for their respective cell cycle phase distribution 
using flow cytometry. Cells were trypsinized, washed with PBS + 
0.2% (w/v) BSA, and resuspended in flow cytometry tubes. Cells 
were then fixed by 70% (v/v) ice-cold ethanol and stored at −20°C 
until analysis. After washing fixed cells once with PBS, ribonuclease 
(RNase) A (50 g/ml) and propidium iodide (PI) (50 g/ml) were 
added to the cells and incubated in the dark at room temperature 
(25°C) for 20 min. The live cell populations were then subjected to 
quantitative measurement of DNA content by flow cytometry using 
an LSRFortessa (BD Biosciences), the cell cycle distribution, and the 
percentage of G2-S-G1 cells determined by the Watson (pragmatic) 
modeling algorithm using FlowJo software (Tree Star).
Telomere FISH
Telomere FISH on metaphase chromosome spreads was performed 
according to standard protocol (44). Briefly, a hybridization mix con-
taining 50 nM Cy3-labeled PNA telomere probe (Cy3-OO-TTAG-
GGTTAGGGTTAGGG 3′) in 70% formamide was spotted on the 
slides with metaphase spreads prepared as described above. The slides 
were covered with coverslips, preheated to 80°C to facilitate DNA 
denaturation, and incubated at room temperature in the dark for a 
minimum of 2 to 3 hours to allow PNA probe annealing to telo-
meres. Following hybridization, the slides were washed two times, 
15 min each, with the solution containing 10 mM tris-HCl (pH 7.2), 
70% formamide, and 0.1% BSA, and then three times, 5 min each, with 
the solution containing 0.1 M tris-HCl (pH 7.2), 0.15 M NaCl, and 
0.08% Tween 20. After washes, the chromosome spreads were de-
hydrated in ethanol series: 5 min in 70, 95, and 100% ethanol, air-
dried, and sealed using a coverslip and a small volume of an antifade 
solution containing DAPI as a DNA counterstain. The images were 
acquired using Zeiss fluorescence microscope and the Metamorph 
software as described above. The PNA probe was ordered from 
PNA Bio Inc. (Thousand Oaks, CA, USA), dissolved at 50 M in 
formamide, and stored at −80°C.
Telomere CO-FISH
Cells were incubated with 10 M 5-bromo-2′-deoxyuridine for 
12 hours, treated with Colcemid (0.5 g/ml) for 4 hours, and harvested. 
Formalin-fixed metaphase spreads were stained with Hoechst 33258 
(0.5 g/ml; Sigma-Aldrich) in PBS for 15 min at room temperature 
before being exposed to ultraviolet (UV) light equivalent to 5.4 × 
103 J/m2. After digestion with 150 U of Exonuclease III (NEB), samples 
were denatured at 85°C for 3 min, and incubated sequentially with 
LNA G–rich (FAM) and PNA C-rich telomeric probe (Exiqon).
Telomere repeat amplification protocol
To measure telomerase activity in the cellular extracts, TRAP was 
performed according to the original protocol (45). Briefly, the cells 
were extracted on ice using standard CHAPS buffer (60 l per 106 
cells) supplemented with a cocktail of protease inhibitors (Roche) 
and 20 U of RNase inhibitor (Applied Biosystems) followed by cen-
trifugation at 18,000g for 30 min at 4°C. The protein concentration 
in the supernatant was measured using Pierce 660-nm Protein Assay, 
and the aliquots equivalent to 960, 480, 240, and 120 ng of protein 
were used to extend 50 ng of the FAM-labeled telomerase substrate 
(FAM-TS oligo) in the 25-l reaction volume. The telomerase ex-
tension products were then amplified by PCR in the same tube using 
the standard ACX and NT primers (45). The TSNT oligo was spiked 
into the reactions to serve as an internal competitor of the telomer-
ase extension products during PCR. The TRAP product was sepa-
rated in the 10% nondenaturing polyacrylamide gel at 240 V for 
2 hours in 1× TRis-Borate EDTA (TBE) buffer, and the FAM fluores-
cence was captured using ChemiDoc MP Imaging System (Bio-Rad).
Southern blot analysis of TRFs
The cells were lysed in the TNES buffer [10 mM tris-HCl (pH 7.5), 
400 mM NaCl, 100 mM EDTA, and 0.6% SDS], supplemented with 
Proteinase K (100 g/ml), and incubated at 55°C for 2 hours. 
Genomic DNA was extracted using a phenol:chloroform (1:1) mixture, 
precipitated with 100% ethanol-acetate, washed with 70% ethanol, 
dissolved in the 10 mM tris-HCl (pH 8.0), and quantified using 
NanoDrop spectrophotometer. The purified DNA (12 g of each 
sample) was digested with Hin fI and Rsa I (1.5 U each per micro-
gram of DNA) at 37°C overnight and separated on 0.8% agarose gel 
in tris-borate buffer. The DNA was transferred from the gel on the 
Hybond N+ membrane using the standard Southern blotting pro-
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DNA was UV–cross-linked onto the nylon membrane and then 
blocked and hybridized with 32P-labeled (CCCTAA)3 probe in the 
Church and Gilbert buffer overnight at 42°C. After washing in the 
Na-phosphate buffer, the membrane was exposed to PhosphorImager 
screen for image acquisition. Telomere/TRF length was quantified 
using TeloTool (46) using manual background adjustment and the 
correction method for probe intensity that is appropriate for stan-
dard Southern blotting where DNA is denatured.
Telomere shortest length assay
TeSLA was performed according to the protocol described by Lai et al. 
(17). Briefly, 50 ng of undigested genomic DNA was ligated with an 
equimolar mixture (50 pM each) of the six TeSLA-T oligonucleotides 
containing seven nucleotides of telomeric C-rich repeats at the 3′ end 
and 22 nucleotides of the unique sequence at the 5′ end. After over-
night ligation at 35°C, genomic DNA was digested with Cvi AII, Bfa I, 
Nde I, and Mse I, the restriction enzymes that create short AT 
or TA overhangs. Digested DNA was then treated with Shrimp 
Alkaline Phosphatase to remove 5′ phosphate from each DNA fragment 
to avoid their ligation to each other during the subsequent step of 
adapter ligation. Upon heat inactivation of phosphatase, partially 
double-stranded AT and TA adapters were added (final concentra-
tion 1 M each) and ligated to the dephosphorylated fragments of 
genomic DNA at 16°C overnight. Following ligation of the adapters, 
genomic DNA was diluted to a final concentration of 20 pg/l, and 
2 to 4 l of it was used in a 25-l PCR reaction to amplify terminal 
fragments using primers complementary to the unique sequences at 
the 5′ ends of the TeSLA-T oligonucleotides and the AT/TA adapters. 
FailSafe polymerase mix (Epicenter) with 1× FailSafe buffer H was 
used to efficiently amplify G-rich telomeric sequences. Entire PCR 
reactions were then loaded onto the 0.85% agarose gel for separa-
tion of the amplified fragments. To specifically visualize telomeric 
fragments, the DNA was transferred from the gel onto the nylon 
membrane by Southern blotting procedure and hybridized with 
the 32P-labeled (CCCTAA)3 probe essentially as described above for 
the Southern blot analysis of TRFs. The sizes of the telomeric frag-
ments were quantified using TeSLA Quant software (21).
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at https://science.org/doi/10.1126/
sciadv.abc7371
View/request a protocol for this paper from Bio-protocol.
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